Seoul Pharma Co. Ltd (018680) — Cash Flow Quality Index
Seoul Pharma Co. Ltd (018680) has a Cash Flow Quality Index of -1.01x as of September 2025. Operating cash flow of ₩-2.66 Billion is below net income of ₩2.62 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 018680 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Seoul Pharma Co. Ltd Cash Flow Quality Index (2008–2024)
Historical Cash Flow Quality Index for Seoul Pharma Co. Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Seoul Pharma Co. Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Seoul Pharma Co. Ltd (2008–2024)
Year-by-year earnings quality comparison for Seoul Pharma Co. Ltd. For live market cap and the full company financial profile, see Seoul Pharma Co. Ltd market capitalisation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -1.77x | ₩-3.01 Billion | ₩1.70 Billion | ▼ -218.3% |
| 2023 | 1.50x | ₩5.26 Billion | ₩3.52 Billion | ▲ +1736.4% |
| 2022 | -0.09x | ₩-78.21 Million | ₩855.09 Million | ▼ -100.7% |
| 2019 | 12.40x | ₩2.93 Billion | ₩236.21 Million | ▲ +1060.9% |
| 2017 | -1.29x | ₩-1.14 Billion | ₩881.45 Million | ▲ +44.2% |
| 2016 | -2.31x | ₩-1.89 Billion | ₩816.80 Million | ▼ -236.5% |
| 2013 | -0.69x | ₩-425.00 Million | ₩618.00 Million | ▼ -138.1% |
| 2012 | 1.81x | ₩9.22 Billion | ₩5.10 Billion | ▼ -50.4% |
| 2011 | 3.64x | ₩4.86 Billion | ₩1.33 Billion | ▲ +248.5% |
| 2009 | 1.05x | ₩1.23 Billion | ₩1.18 Billion | ▲ +175.0% |
| 2008 | -1.39x | ₩-755.68 Million | ₩542.04 Million | — |